207 related articles for article (PubMed ID: 22069315)
1. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
[TBL] [Abstract][Full Text] [Related]
2. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2009 May; 284(20):13570-13576. PubMed ID: 19336395
[TBL] [Abstract][Full Text] [Related]
3. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging.
Macdonald-Obermann JL; Piwnica-Worms D; Pike LJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):137-42. PubMed ID: 22190492
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
Alvarado D; Klein DE; Lemmon MA
Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
[TBL] [Abstract][Full Text] [Related]
5. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
Adak S; DeAndrade D; Pike LJ
J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
Macdonald-Obermann JL; Pike LJ
Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
[TBL] [Abstract][Full Text] [Related]
8. Asp-960/Glu-961 controls the movement of the C-terminal tail of the epidermal growth factor receptor to regulate asymmetric dimer formation.
Yang KS; Macdonald-Obermann JL; Piwnica-Worms D; Pike LJ
J Biol Chem; 2010 Jul; 285(31):24014-22. PubMed ID: 20507979
[TBL] [Abstract][Full Text] [Related]
9. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
Arkhipov A; Shan Y; Kim ET; Shaw DE
PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.
Macdonald JL; Pike LJ
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):112-7. PubMed ID: 18165319
[TBL] [Abstract][Full Text] [Related]
11. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
[TBL] [Abstract][Full Text] [Related]
12. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence.
He L; Hristova K
Sci Rep; 2012; 2():854. PubMed ID: 23152945
[TBL] [Abstract][Full Text] [Related]
13. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
[TBL] [Abstract][Full Text] [Related]
14. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
[TBL] [Abstract][Full Text] [Related]
15. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
[TBL] [Abstract][Full Text] [Related]
16. Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.
Yang KS; Ilagan MX; Piwnica-Worms D; Pike LJ
J Biol Chem; 2009 Mar; 284(12):7474-82. PubMed ID: 19171934
[TBL] [Abstract][Full Text] [Related]
17. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the catalytic activity of the EGF receptor.
Endres NF; Engel K; Das R; Kovacs E; Kuriyan J
Curr Opin Struct Biol; 2011 Dec; 21(6):777-84. PubMed ID: 21868214
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
20. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
Kozer N; Clayton AHA
Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
